Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT Trading

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Apr 29, 2022 11:47am

158 Views

Post# 34642522

RE:TLT Trading

Yes a rapid rise in share price, like you describe, is especially possible if any of this SP walkdown includes shorting. ;-)

xodcode wrote: Hard to believe that with 200 million shares, TLT rarely trades over 200 thousand Canadian shares on any given day.

As such, it doesn't take much to move TLT's price. It hasn't taken a huge number of shares to drivr the price back to $0.27 from recent highs.

Any positive "vaccine" news and/or "bladder cancer" news, given the lack of sellers that we have seen during this recent TLT price drop, will see a rapid recovery in share price, as daily volume increases, probably well above previous highs.

I'm a holder, and buyer when funds are available, of TLT shares as my crystal ball, like some others here, see $2 to $10, on any convincingly positive TLT news.